Cotización Zymergen - ZY

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

2.43

Postura de Compra

2.30

Postura de Venta

2.31

Volume Operado de la Acción

0.00 Rango del Día 0.00

0.00 Rango de 52 semanas 0.00

Precio Anterior

2.43

Precio de Apertura

Hora

Última hora de negociación

Volumen promedio (3 m)

Volumen financiero

Precio Promedio Ponderado

Ginkgo Bioworks Completes Acquisition of Zymergen

Ginkgo Bioworks Completes Acquisition of Zymergen PR Newswire BOSTON and EMERYVILLE, Calif., Oct. 19, 2022 BOSTON and EMERYVILLE, Calif., Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks...

Ginkgo to Acquire Zymergen

Ginkgo to Acquire Zymergen PR Newswire BOSTON and EMERYVILLE, Calif., July 25, 2022 Acquisition is expected to accelerate the development of Ginkgo's innovative horizontal synthetic biology...

Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform

EMERYVILLE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it has expanded its agreement with Octant to further scale their next-generation...

Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications

EMERYVILLE, Calif., June 28, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced an R&D supply agreement to provide Zymergen Z2TM polyimide powder to...

Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform

EMERYVILLE, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced it has entered into an agreement with Octant for the sale of a modular...

Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)

- Leaps by Bayer led Series B investment in Senti Bio in 2021; Additional Convertible Note financing expands committed capital to PIPE investment associated with previously announced Business...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
PALIPalisade Bio Inc	US$ 2.95 (110.71%)	1.61M
DBVTDBV Technologies SA	US$ 4.79 (45.59%)	1.37M
CTHRCharles and Colvard Ltd	US$ 2.035 (29.61%)	429.91k
WHLRWheeler Real Estate Investment Trust Inc	US$ 5.50 (23.32%)	76.76k
ONVOOrganovo Holdings Inc	US$ 0.498 (21.61%)	1
PNBKPatriot National Bancorp Inc	US$ 1.08 (-58.78%)	12
AVGRAvinger Inc	US$ 0.40 (-51.22%)	2.54k
SPGCSacks Parente Golf Inc	US$ 0.8796 (-37.17%)	867
BCTXBriaCell Therapeutics Corporation	US$ 0.76 (-30.91%)	23.18k
SFHGSamfine Creation Holdings Group Ltd	US$ 2.33 (-23.61%)	33.08k
AMPGAmplitech Group Inc	US$ 2.03 (5.18%)	1.7M
PALIPalisade Bio Inc	US$ 2.95 (110.71%)	1.61M
DBVTDBV Technologies SA	US$ 4.79 (45.59%)	1.37M
RGTIRigetti Computing Inc	US$ 6.77 (-8.27%)	975.56k
LAESSEALSQ Corporation	US$ 1.12 (-2.61%)	794.31k